Cytori Therapeutics Inc (NASDAQ:CYTX) announced that its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution® System by the State Food and …
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it will formally launch and showcase its new Celase® GMP enzyme at the 2015 International Society for …
In a research report issued today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Cytori Therapeutics Inc (NASDAQ:CYTX) with a $6 price …
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) issued a positive opinion toward Cytori’s …
In a research report released this morning, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Cytori Therapeutics Inc (NASDAQ:CYTX) with a price target …
Roth Capital’s healthcare analyst Joseph Pantginis weighed in with a few insights on Cytori Therapeutics Inc (NASDAQ:CYTX), as the company announced that the first patient has been …
In a research report released Friday, Maxim Group analyst Jason Kolbert maintained a Buy rating on Cytori Therapeutics (NASDAQ:CYTX) with a $6.00 price …
Roth Capital analyst Joseph Pantginis is out with a research report on Cytori Therapeutics (NASDAQ:CYTX) reiterating a Buy rating and a $3.50 price target, which …
In a research report issued today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Cytori Therapeutics (NASDAQ:CYTX) and raised his price …
In a research report published Thursday, Roth Capital analyst Joseph Pantginis maintained a Buy rating on Cytori Therapeutics (NASDAQ:CYTX) with a $3.50 price …
